Company / Working Capital per Share
CRESCENT BIOPHARMA, INC. Working Capital per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$196.92
FY2025
5-year range
$1.79 / $196.92
FY2021-FY2025
Trend
+3745.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share changed +3746% YoY in FY2025, a notable deviation from the 4-year average annual change of +956%.
Based on SEC 10-K filings.
196.92 in FY2025 with a 10-year CAGR of +57.6%.
Improved from $1.79 to $196.92 over the past 9 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +57.6%
Key checks
Key Insights
- In FY2025, working capital per share increased 3745.9% year-over-year.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $196.92 | +3745.9% |
| FY2017 | $5.12 | +185.3% |
| FY2016 | $1.79 | -13.9% |
| FY2015 | $2.09 | -94.0% |
| FY2014 | $34.81 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026